Bristol-based biotechnology company Mykor has secured £4 million in funding to accelerate the commercial scale-up of its low-carbon construction systems grown from industrial and agricultural waste.
The round was led by Clean Growth Fund, with participation from the British Business Bank’s South West Investment Fund through The FSE Group, Green Angel Ventures, and additional support from Innovate UK’s investor partnership programme.
The latest financing brings Mykor’s total funding to £7.5 million, including £5.5 million in equity investment and £2 million in grants.
Growing Construction Materials From Waste Streams
Founded in 2021, Mykor is developing industrial biofabrication technologies that transform agricultural and industrial waste into scalable low-carbon construction products.
The company combines engineered mycelium strains, green chemistry additives, and automated manufacturing systems to produce construction materials ranging from prefabricated wall systems to cavity wall insulation.
Rather than operating as a traditional single-product manufacturer, Mykor positions itself as a technology and process platform that allows contractors and manufacturers to integrate biomaterials directly into existing construction supply chains and production systems.
Advertisement
Addressing Construction’s Carbon Challenge
The built environment currently accounts for approximately 39% of global emissions, with embodied carbon from materials contributing around 11% and operational energy use contributing a further 28%.
Mykor aims to address both challenges simultaneously by producing renewable, lower-carbon alternatives to traditional insulation and construction systems.
Its first commercial product, MykoSIP, is a preassembled partition wall system that delivers estimated carbon savings of around 23kgCO₂e per square metre compared to conventional alternatives.
The company says the system achieves at least 50% carbon savings while maintaining comparable thermal, acoustic, fire safety, and construction performance standards. The panels also use 90% less water and 40% less electricity than polystyrene-based alternatives.
Scaling Production Across Global Markets
Mykor says it is already delivering live construction projects and has secured two large offtake agreements with UK and European contractors worth a combined £338 million.
The new funding will support the expansion of manufacturing capacity and help establish a repeatable production model that can be deployed across key international markets.
“We built Mykor around the belief that decarbonising construction cannot come at the expense of cost, performance, or practicality,” said Olivia Page.
“The real challenge has been industrialising biomaterials at commercial scale and integrating them into existing construction supply chains.”
About Mykor
Mykor is a UK biotechnology company developing scalable low-carbon construction systems using industrial and agricultural waste streams. The company combines engineered mycelium, green chemistry, and automated manufacturing technologies to create sustainable construction materials designed for mainstream industrial adoption.
